Equity Details
Price & Market Data
Price: $1.53
Daily Change: $0.00 / 0.00%
Daily Range: $1.46 - $1.57
Market Cap: $198,524,240
Daily Volume: 75,112
Performance Metrics
1 Week: 9.09%
1 Month: 35.65%
3 Months: 10.64%
6 Months: -10.86%
1 Year: 4.00%
YTD: 4.70%
About Tiziana Life Sciences Ltd (TLSA)
Detailed report on Tiziana Life Sciences Ltd (TLSA). Current price: 1.53, daily change: $0.00 / 0.00%. Market cap: 198,524,240. Explore all performance metrics.
Company Details
Employees: 10
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United Kingdom
Details
Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.